Paenibacillus polymyxa PKB1 produces variants of polymyxin B-type antibiotics

Mohamed Shaheen1, Jingru Li, Avena C Ross

  • 1Department of Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada.

Chemistry & Biology
|December 27, 2011
PubMed

Insights

Researchers sequenced the polymyxin biosynthesis gene cluster in Paenibacillus polymyxa PKB1. This revealed the genetic basis for producing polymyxin variants, including those with D-2,4-diaminobutyrate.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Polymyxins are crucial cationic lipopeptide antibiotics effective against Gram-negative bacteria.
  • Understanding polymyxin biosynthesis is vital for developing new antimicrobial strategies.

Purpose of the Study:

  • To sequence and analyze the gene cluster responsible for polymyxin biosynthesis in Paenibacillus polymyxa PKB1.
  • To elucidate the genetic basis for polymyxin variant production.

Main Methods:

  • Gene sequencing of the polymyxin biosynthesis cluster.
  • Gene disruption and deletion experiments.
  • High-performance liquid chromatography (HPLC) and high-resolution mass spectrometry (HRMS) for metabolite identification.
  • MS/MS sequencing and stereochemical analysis.

Main Results:

  • A 40.8 kb gene cluster containing three nonribosomal peptide synthetase (NRPS) genes and two ABC transporter genes was identified.
  • Disruption of an NRPS gene completely halted antibiotic production.
  • Deletion of transporter genes partially reduced antibiotic production.
  • Two polymyxin B variants, differing in amino acid position 3 (D-2,4-diaminobutyrate), were identified and confirmed.

Conclusions:

  • The sequenced gene cluster encodes the biosynthesis of polymyxins in P. polymyxa PKB1.
  • The NRPS genes are essential for polymyxin production, while transporter genes modulate it.
  • The study identified novel polymyxin variants, expanding the known polymyxin structural diversity.

Related Concept Videos

Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection00:57

Antibiotic Selection

Overview